Atriva Therapeutics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Loan | Alive

Total Raised


Last Raised

$28.38M | 2 yrs ago

About Atriva Therapeutics

Atriva Therapeutics develops antiviral therapies. Atriva's product platform draws from selected repurposed MEK kinase inhibitors and focuses on acute viral infections like influenza, RSV or MERS.

Atriva Therapeutics Headquarter Location

Christophstrasse 32

Tuebingen, 72072,


+49 7071 859 7673

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Atriva Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Atriva Therapeutics is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Atriva Therapeutics Patents

Atriva Therapeutics has filed 6 patents.

The 3 most popular patent topics include:

  • Epidemiology
  • Inflammations
  • Influenza
patents chart

Application Date

Grant Date


Related Topics




Influenza, Epidemiology, Animal virology, Virology, Pseudomonadales


Application Date


Grant Date



Related Topics

Influenza, Epidemiology, Animal virology, Virology, Pseudomonadales



Atriva Therapeutics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Atriva Therapeutics Rank

  • When was Atriva Therapeutics founded?

    Atriva Therapeutics was founded in 2015.

  • Where is Atriva Therapeutics's headquarters?

    Atriva Therapeutics's headquarters is located at Christophstrasse 32, Tuebingen.

  • What is Atriva Therapeutics's latest funding round?

    Atriva Therapeutics's latest funding round is Loan.

  • How much did Atriva Therapeutics raise?

    Atriva Therapeutics raised a total of $42.17M.

  • Who are the investors of Atriva Therapeutics?

    Investors of Atriva Therapeutics include European Investment Bank, High-Tech Grunderfonds, Meneldor and Stichting Participatie Atriva.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.